PAVmed Inc. Quarterly Debt-to-equity in % from Q3 2017 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PAVmed Inc. quarterly Debt-to-equity history and growth rate from Q3 2017 to Q4 2024.
  • PAVmed Inc. Debt-to-equity for the quarter ending December 31, 2024 was -129 %, a 13.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 -129 +19.7 +13.3% Dec 31, 2024
Q3 2024 -106 +91.3 +46.4% Sep 30, 2024
Q2 2024 -96.3 +265 +73.3% Jun 30, 2024
Q1 2024 -115 +22.4K +99.5% Mar 31, 2024
Q4 2023 -149 -368 -168% Dec 31, 2023
Q3 2023 -197 -278 -343% Sep 30, 2023
Q2 2023 -361 -407 -881% Jun 30, 2023
Q1 2023 -22.5K -22.5K -103652% Mar 31, 2023
Q4 2022 220 +207 +1640% Dec 31, 2022
Q3 2022 80.9 +52.7 +187% Sep 30, 2022
Q2 2022 46.2 -19.7 -29.9% Jun 30, 2022
Q1 2022 21.7 -231 -91.4% Mar 31, 2022
Q4 2021 12.6 +263 Dec 31, 2021
Q3 2021 28.2 +226 Sep 30, 2021
Q2 2021 65.9 +274 Jun 30, 2021
Q1 2021 252 +495 Mar 31, 2021
Q4 2020 -251 +46.1 +15.5% Dec 31, 2020
Q3 2020 -198 +131 +39.8% Sep 30, 2020
Q2 2020 -208 +426 +67.2% Jun 30, 2020
Q1 2020 -243 -1.51K -119% Mar 31, 2020
Q4 2019 -297 -603 -197% Dec 31, 2019
Q3 2019 -329 -571 -236% Sep 30, 2019
Q2 2019 -634 +504 +44.3% Jun 30, 2019
Q1 2019 1.27K +1.43K Mar 31, 2019
Q4 2018 306 +440 Dec 31, 2018
Q3 2018 243 +377 Sep 30, 2018
Q2 2018 -1.14K Jun 30, 2018
Q1 2018 -165 Mar 31, 2018
Q4 2017 -134 Dec 31, 2017
Q3 2017 -135 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.